top of page
The Professional Network for Healthcare Experts
Third Rock Ventures signs AI antibody discovery partnership with Funnel Biosciences worth up to $2.16 billion
Third Rock Ventures has entered a potentially $2.16 billion AI-enabled antibody discovery collaboration with China's Funnel Biosciences, combining epitope-guided molecular design with multiple venture-selected drug targets.
nuaxia
27 minutes ago2 min read
GSK expands AI drug discovery collaboration with Chai Discovery following successful laboratory evaluation
GSK has expanded its collaboration with Chai Discovery to apply AI-powered protein modelling and molecular design tools across pharmaceutical drug discovery following successful laboratory validation.
nuaxia
Oct 142 min read
Pfizer signs Enodia Therapeutics research and licensing agreement worth more than $500 million for Sec61 protein degradation
Pfizer has entered a research and licensing collaboration with Enodia Therapeutics worth potentially more than $500 million to develop small-molecule therapies targeting protein synthesis through Sec61 inhibition.
nuaxia
Oct 142 min read
Atavistik Bio and Roche sign allosteric drug discovery collaboration worth up to $1.9bn
The collaboration gives Roche access to Atavistik Bio's AMPS platform to discover allosteric small molecules across cardiovascular, renal and metabolic disease targets.
nuaxia
Sep 281 min read
Lilly and InnoCare sign drug-discovery collaboration worth up to $3.35bn
Lilly and InnoCare have entered a multi-target research and licensing collaboration potentially worth $3.35 billion to discover and develop new medicines.
nuaxia
Sep 252 min read
bottom of page